Regeneron Pharmaceuticals
Regeneron's Preclinical Manufacturing & Process Development group is seeking a Process Development Associate II to develop conjugation and purification processes for bioconjugating proteins to small-molecules. The role involves collaborating with cross-functional teams to optimize processes using Quality by Design principles, ensuring they are suitable for GMP production and successful technology transfer to CDMOs. Key duties include leading bench work for scalable process design, utilizing statistical design of experiments, and maintaining rigorous lab safety and documentation standards.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
9% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Senior Research Associate / Associate Scientist – Protein Sciences
ImmunEdge, Inc
Bioconjugation Process Development and Manufacturing Lead
Telix Pharmaceuticals
Scientist II, BioConjugation
Astellas
Scientist, Bioconjugation
Dyne Therapeutics
Senior Research Associate/Scientist I
ImmunEdge, Inc
Scientist I
Atrium Therapeutics